Literature DB >> 24922444

Effect of disease stage on progression of hydroxychloroquine retinopathy.

Michael F Marmor1, Julia Hu1.   

Abstract

IMPORTANCE: Hydroxychloroquine sulfate retinopathy can progress after the drug is stopped. It is not clear how this relates to the stage of retinopathy or whether early screening with modern imaging technology can prevent progression and visual loss.
OBJECTIVE: To determine the relationship between progression of retinopathy and the severity of disease using objective data from optical coherence tomography and assess the value of early screening for the toxic effects of hydroxychloroquine. DESIGN, SETTING, AND PARTICIPANTS: Clinical findings in patients with hydroxychloroquine retinopathy were monitored with repeated anatomical and functional examinations for 13 to 40 months after the drug was stopped in a referral practice in a university medical center. Eleven patients participated, with the severity of toxic effects categorized as early (patchy parafoveal damage shown on field or objective testing), moderate (a 50%-100% parafoveal ring of optical coherence tomography thinning but intact retinal pigment epithelium), and severe (visible bull's-eye damage). MAIN OUTCOMES AND MEASURES: Visual acuity, white 10-2 visual field pattern density plots, fundus autofluorescence, spectral-density optical coherence tomography cross sections, thickness (from cube diagrams), and ellipsoid zone length.
RESULTS: Visual acuity and visual fields showed no consistent change. Fundus autofluorescence showed little or no change except in severe cases in which the bull's-eye damage expanded progressively. Optical coherence tomography cross sections showed little visible change in early and moderate cases but progressive foveal thinning (approximately 7 μm/y) and loss of ellipsoid zone (in the range of 100 μm/y) in severe cases, which was confirmed by quantitative measurements. The measurements also showed some foveal thinning (approximately 4 μm/y) and deepening of parafoveal loss in moderate cases, but the breadth of the ellipsoid zone remained constant in both early and moderate cases. A few cases showed a suggestion of ellipsoid zone improvement. CONCLUSIONS AND RELEVANCE: Patients with hydroxychloroquine retinopathy involving the retinal pigment epithelium demonstrated progressive damage on optical coherence tomography for at least 3 years after the drug was discontinued, including loss of foveal thickness and cone structure. Cases recognized before retinal pigment epithelium damage retained foveal architecture with little retinal thinning. Early recognition of hydroxychloroquine toxic effects before any fundus changes are visible, using visual fields and optical coherence tomography (along with fundus autofluorescence and multifocal electroretinography as indicated), will greatly minimize late progression and the risk of visual loss.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24922444     DOI: 10.1001/jamaophthalmol.2014.1099

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  25 in total

1.  MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY: The Hard-Risk-1 Study.

Authors:  Mustafa Iftikhar; Ramandeep Kaur; April Nefalar; Bushra Usmani; Saleema Kherani; Isra Rashid; Etienne Schönbach; Michelle Petri; Hendrik P N Scholl; Syed M Shah
Journal:  Retina       Date:  2019-03       Impact factor: 4.256

2.  Delayed progression of bull's eye maculopathy.

Authors:  Sunila Jain; Neel Gautam Jain
Journal:  BMJ Case Rep       Date:  2017-06-08

3.  Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.

Authors:  Luis de Sisternes; Julia Hu; Daniel L Rubin; Michael F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

4.  Volumetric ellipsoid zone mapping for enhanced visualisation of outer retinal integrity with optical coherence tomography.

Authors:  Yuji Itoh; Amit Vasanji; Justis P Ehlers
Journal:  Br J Ophthalmol       Date:  2015-07-22       Impact factor: 4.638

Review 5.  A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.

Authors:  Nathalie Costedoat-Chalumeau; Bertrand Dunogué; Gaëlle Leroux; Nathalie Morel; Moez Jallouli; Véronique Le Guern; Jean-Charles Piette; Antoine P Brézin; Ronald B Melles; Michael F Marmor
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 6.  Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss.

Authors:  Tanyatuth Padungkiatsagul; Loh-Shan Leung; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2020-09-15       Impact factor: 5.081

Review 7.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

8.  Highly Accelerated Onset of Hydroxychloroquine Macular Retinopathy.

Authors:  Ethan M Stern; Jordan S Johnson; Donald A Mazzulla
Journal:  Ochsner J       Date:  2017

9.  Evaluation of optical coherence tomography angiography parameters in patients treated with Hydroxychloroquine.

Authors:  Mohammadreza Akhlaghi; Farzan Kianersi; Hamed Radmehr; Alireza Dehghani; Afsaneh Naderi Beni; Pegah Noorshargh
Journal:  BMC Ophthalmol       Date:  2021-05-11       Impact factor: 2.209

10.  Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.

Authors:  Marilita M Moschos; Eirini Nitoda; Irini P Chatziralli; Zisis Gatzioufas; Chryssanthi Koutsandrea; George Kitsos
Journal:  Drug Des Devel Ther       Date:  2015-06-11       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.